Research assessed methylated Septin9 as a blood-based biomarker for colorectal cancer diagnosis, recurrence monitoring, and prognosis. (Clinica Chimica Acta)
Liquid biopsy marker mSEPT9 evaluated for CRC screening and monitoring
The CRC Digest
The CRC Digest
Research assessed methylated Septin9 as a blood-based biomarker for colorectal cancer diagnosis, recurrence monitoring, and prognosis. (Clinica Chimica Acta)